[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pharmacy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pharmacy":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,68],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100568432","pharmacist-physiotherapist-collaborative-management-for-early-knee-osteoarthritis-100568432",false,"NCT06681142","Pharmacist-physiotherapist Collaborative Management for Early Knee Osteoarthritis","PACE-OA","Inclusion Criteria:\n\n* regularly experiencing pain, aching, or stiffness in and\u002For around the knee for at least 1 month\n* complete the screening PhIT-OA questionnaire\n\nExclusion Criteria:\n\n* Prior total knee replacement or on the waitlist to have your knee replaced\n* Knee surgery within the previous 4 months\n* History of acute injury to knee within previous 6 months\n* Unable to speak and read English\n* Unwilling or unable to visit a physiotherapist at a community physiotherapy clinic (specifically the dates and times of the partnering physiotherapy clinic)\n* Previous physician-diagnosed inflammatory arthritis (including this list): Rheumatoid arthritis, Psoriatic arthritis, Ankylosing spondylitis, Lupus, Gout\n* Physician diagnosed fibromyalgia\n* A sudden, severely painful, hot, swollen joint at any time in the past\n* History of the following medications: csDMARD or bDMARD or tsDMARD, Immunosuppressive, Allopurinol or febuxostat, Colchicine\n* Received a knee joint injection in the past 3 months or have one scheduled in the next 3 months\n* Has completed the GLA:D Hip and Knee program at all in the past","ALL","50 Years",{"count":19,"type":20},125,"ESTIMATED","INTERVENTIONAL",[23],"NA","Osteoarthritis (OA) is a slowly progressive chronic condition that is associated with aging and is characterized as joint pain. Individuals with early-stage OA usually do not seek medical attention. If and when they do, patients more often present to a pharmacy for over-the-counter medications.\n\nThe investigators want to leverage community pharmacists' accessibility and scope of practice to best support patients with early knee OA. Given there are no disease-modifying treatments for OA, treatment guidelines center on patient education, self-management, and exercise, with medications playing a supporting role. Self-management is an effective strategy that provides a solid foundation for managing this progressive chronic condition and health care professionals like physiotherapists and pharmacists can help with the development and application of these skills.",[26,27,28],"Osteoarthritis (OA) of the Knee","Physiotherapy","Pharmacy","RECRUITING","2026-06-23",{"date":32,"type":33},"2026-06-26","ACTUAL",{"date":35,"type":33},"2025-08-13",{"date":37,"type":20},"2027-09",{"name":39,"class":40},"University of Alberta","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":41},"100613166","prep--soccer-a-program-for-pharmacy-chains-to-increase-prep-awareness-and-access-among-men-100613166","NCT07263048","PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men","Inclusion Criteria:\n\n* Provide their informed consent to participate.\n* Demonstrate willingness to comply with all study procedures and be available for the study duration.\n* Ages 18 to 54 years of age.\n* A man.\n* Self-report any of the following behaviors and\u002For health conditions\n\n  1. Diagnosed with bacterial sexually transmitted infection (e.g., syphilis, gonorrhea, or chlamydia)\n  2. Sex with a partner who is living with HIV\n  3. Sex without a condom with two or more partners whose HIV status were unknown\n  4. Injection drug use and sharing injection equipment\n* Have been without a PrEP prescription for at least 24 weeks.\n\nExclusion Criteria:\n\n* Diminished capacity to consent due to:\n\n  1. Inability to provide informed consent (e.g., cognitive impairment), or\n  2. Presence of severe psychiatric symptoms (e.g., mania, psychosis) that impair the ability to provide informed consent, as assessed by interviewers trained in CITI Human Subjects Research and NIH Good Clinical Practice.\n* Younger than 18 or older than 54 years of age.\n* A woman.\n* Does not self-report any of the following behaviors and\u002For health conditions\n\n  1. Diagnosed with bacterial sexually transmitted infection (e.g., syphilis, gonorrhea, or chlamydia)\n  2. Sex with a partner who is living with HIV\n  3. Sex without a condom with two or more partners whose HIV status were unknown\n  4. Injection drug use and sharing injection equipment\n* Has had an active PrEP prescription within the past 24 weeks.\n* Living with HIV (e.g. has received an HIV diagnosis).\n* Planning to move outside of Miami-Dade or Broward counties in the next 7 months.","MALE","18 Years","54 Years",{"count":52,"type":20},800,[23],"This type 3 Hybrid Effectiveness-Implementation study will evaluate PrEP \\& Soccer, a multicomponent and multilevel implementation strategy delivered by a pharmacy chain to increase PrEP knowledge and initial PrEP appointment attendance among men. Using mixed methods and implementation science approaches, this parallel cluster randomized controlled study will assess key implementation factors at CVS Health pharmacy locations assigned either to the PrEP \\& Soccer intervention or to a general CVS Health service information-only control.",[56,57,28],"HIV Prevention","Latino Men Who Have Sex With Men","NOT_YET_RECRUITING","2025-12-02",{"date":61,"type":33},"2025-12-04",{"date":63,"type":20},"2026-07",{"date":65,"type":20},"2029-07",{"name":67,"class":40},"University of Miami",{"id":69,"slug":70,"hasResults":11,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":4,"eligibilityCriteria":74,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":75,"targetDuration":4,"studyType":21,"phases":77,"briefSummary":78,"conditions":79,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":41},"100559625","the-road-20-to-sustainable-medication-use-redispensing-unused-oral-anticancer-drugs-100559625","NCT06566560","The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs","Cost-savings and Environmental Impact Obtained From Redispensing Unused Oral Anticancer Drugs","Inclusion Criteria:\n\n* Patients of all ages\n* A clinical diagnosis of cancer using an oral anticancer drug that requires storage at room temperature according to the Summary of Product Characteristics (SmPC).\n\nExclusion Criteria:\n\n* Patients that do not understand the Dutch or English language, in written or spoken.\n* Patients receiving prescriptions that contain an amount of tablets that deviates from the regular package size, resulting in the pharmacy dispensing an opened package",{"count":76,"type":20},2500,[23],"The goal of this prospective intervention study is to investigate the effectiveness of redispensing unused oral anticancer drugs.\n\nThe main questions it aims to answer are:\n\n* What are the cost-savings of redispensing unused oral anticancer drugs?\n* What is the environmental impact of redispensing unused oral anticancer drugs?\n\nResearchers will compare redispensing unused oral anticancer drugs to the standard practice of disposal.\n\nParticipants will receive their oral anticancer drugs in a sealed bag with a temperature indicator if needed. They will be asked to return any unused oral anticancer drugs to the pharmacy during their next visit to the hospital.",[80,81,28,82],"Cancer","Oncology","Drug Prescriptions","2024-08-20",{"date":85,"type":33},"2024-08-22",{"date":87,"type":33},"2024-01-10",{"date":89,"type":20},"2024-12-31",{"name":91,"class":40},"Radboud University Medical Center"]